Replies

If the active ingredients in marijuana is a valid treatment for certain ailments then drug companies can and will go through the normal procedures to get it approved through the FDA. There is no reason or need for the states to be subverting federal restrictions. This current “legalization” effort is a complete farce and anyone familiar with FDA regulations and procedures can tell you so. Marijuana has been proven to be effective under only certain conditions for certain maladies in clinical studies. When the risks are factored in... most legitimate drug companies want nothing to do with it.

You’re talking to ma about drugs and FDA approval and sickness. My comment was about none of that stuff.

The rhetoric of “I’m a victim, so I win the argument” is distasteful to me. That’s all I’m saying.

Drug companies are not in the business of manufacturing plant extracts. Their business model is developing novel compounds that treat a disease or symptom, having patents awarded and then selling the compound exclusively for what ever price the market will bear.

Their is nothing in canibus that Big Pharma can profit from.

But, keeping it prohibited does guarantee that patients will have to use their less effective and much more dangerous alternatives, that they do, in fact, profit handsomely from.

Interesting fact: As a medical researcher, if one wanted to gain federal approval from the NIDA to study the effects of canibus, my thesis would have to state that I'm attempting to prove a detrimental effect. If they suspect that your are studying therapeutic effects, your petition will be denied.